Since TOP2A has been found to correlate well with Ki-67 in a number of human diseases, Willman et al.[5] suggested that similar prognostic information might be obtained by TOP2A IHC, with an advantage that the enzyme is the target of drugs being used for treating PCa patients. The gene discussed is MKI67; the disease is posterior cortical atrophy.